Arthroplasty
Bupivacaine provides better post-operative pain relief in comparison to placebo
J Arthroplasty. 2012 May;27(5):673-8.e1. Epub 2011 Sep 23105 patients scheduled to undergo unilateral total knee arthroplasty were randomized to receive either a low dose or a high dose of bupivacaine or a placebo. Results from early post-operative follow-up indicated that patients who received placebo were three times as likely to experience pain. However, this difference between the three groups disappeared at 1 day post-operative follow-up. Additionally, no significant differences between the two groups were found in regards to post-operative nausea or sedation.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
